Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges.
暂无分享,去创建一个
Ophir Vermesh | Mohammad Raoufi | Morteza Mahmoudi | Amir Ata Saei | Zahra Bakhtiary | M. Mahmoudi | Ophir Vermesh | Mohammad Raoufi | A. Saei | Zahra Bakhtiary | M. Hajipour | Mohammad J Hajipour | Z. Bakhtiary | O. Vermesh
[1] C. Arús,et al. Efficient γ-amino-proline-derived cell penetrating peptide-superparamagnetic iron oxide nanoparticle conjugates via aniline-catalyzed oxime chemistry as bimodal imaging nanoagents. , 2012, Chemical communications.
[2] Albert Duschl,et al. Time evolution of the nanoparticle protein corona. , 2010, ACS nano.
[3] Morteza Mahmoudi,et al. Personalized protein coronas: a "key" factor at the nanobiointerface. , 2014, Biomaterials science.
[4] V. Rotello,et al. Contrasting effects of exterior and interior hydrophobic moieties in the complexation of amino acid functionalized gold clusters with alpha-chymotrypsin. , 2005, Organic Letters.
[5] Mohammad Abdolahi,et al. Synthesis and in vitro evaluation of MR molecular imaging probes using J591 mAb-conjugated SPIONs for specific detection of prostate cancer. , 2013, Contrast media & molecular imaging.
[6] Weihong Tan,et al. Cancer cell targeting using multiple aptamers conjugated on nanorods. , 2008, Analytical chemistry.
[7] Raimo Hartmann,et al. Temperature: the "ignored" factor at the NanoBio interface. , 2013, ACS nano.
[8] R. Nagle,et al. Human Cell Surface Receptors as Molecular Imaging Candidates for Metastatic Prostate Cancer. , 2009, The open prostate cancer journal.
[9] T. Yamaguchi,et al. The role of monoclonal antibody A7 as a drug modifier in cancer therapy , 2005, Cancer Immunology, Immunotherapy.
[10] Alex M. Fichtenholtz,et al. Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. , 2006, Small.
[11] Giulio Caracciolo,et al. Size and charge of nanoparticles following incubation with human plasma of healthy and pancreatic cancer patients. , 2014, Colloids and surfaces. B, Biointerfaces.
[12] Sara Linse,et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[13] Jinwoo Cheon,et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging , 2007, Nature Medicine.
[14] Jin-Sil Choi,et al. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. , 2005, Journal of the American Chemical Society.
[15] D. Shangguan,et al. Development of DNA aptamers using Cell-SELEX , 2010, Nature Protocols.
[16] R. Narain,et al. Synthesis of biotinylated α-D-mannoside or N-acetyl β-D-glucosaminoside decorated gold nanoparticles: study of their biomolecular recognition with Con A and WGA Lectins. , 2010, Bioconjugate chemistry.
[17] Kimberly A Kelly,et al. M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer. , 2012, Nature nanotechnology.
[18] M. Mahmoudi,et al. Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide. , 2015, Nanoscale.
[19] Ildar Khalidov,et al. Targeted near-IR hybrid magnetic nanoparticles for in vivo cancer therapy and imaging. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[20] 高金浩,et al. Octapod iron oxide nanoparticles as high-performance T2 contrast agents for magnetic resonance imaging , 2013 .
[21] M. Mahmoudi,et al. Protein-nanoparticle interactions: opportunities and challenges. , 2011, Chemical reviews.
[22] Dar-Bin Shieh,et al. Iron oxide nanoparticles for targeted cancer imaging and diagnostics. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[23] M. Robson,et al. Molecular MRI enables early and sensitive detection of brain metastases , 2012, Proceedings of the National Academy of Sciences.
[24] C. Sharma,et al. Fluorescent and superparamagnetic hybrid quantum clusters for magnetic separation and imaging of cancer cells from blood. , 2011, Nanoscale.
[25] Shiyuan Liu,et al. Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Noninvasively Characterizing the Different Αvβ3 Expression Patterns in Lung Cancers with Rgd-uspio Using a Clinical 3.0t Mr Scanner , 2022 .
[26] David C. Zhu,et al. Magnetic glyco-nanoparticles: a tool to detect, differentiate, and unlock the glyco-codes of cancer via magnetic resonance imaging. , 2010, Journal of the American Chemical Society.
[27] M. Kitajima,et al. Magnetic resonance imaging of esophageal squamous cell carcinoma using magnetite particles coated with anti‐epidermal growth factor receptor antibody , 1998, International journal of cancer.
[28] M. Mahmoudi,et al. Plasma concentration gradient influences the protein corona decoration on nanoparticles , 2013 .
[29] W. Duan,et al. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture. , 2013, Analytical chemistry.
[30] A. Milani,et al. Crucial role of the protein corona for the specific targeting of nanoparticles. , 2015, Nanomedicine.
[31] Hui Mao,et al. Improving the Magnetic Resonance Imaging Contrast and Detection Methods with Engineered Magnetic Nanoparticles , 2012, Theranostics.
[32] Wolfhard Semmler,et al. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. , 2007, Cancer research.
[33] David A. Cheresh,et al. Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging , 1998, Nature Medicine.
[34] Wei Wei,et al. Metastatic patterns in adenocarcinoma , 2006, Cancer.
[35] K A Chester,et al. Clinical issues in antibody design. , 1995, Trends in biotechnology.
[36] L. Tiefenauer,et al. Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging. , 1993, Bioconjugate chemistry.
[37] R. J. Lee,et al. Targeted drug delivery via the folate receptor. , 2000, Advanced drug delivery reviews.
[38] Yi-Xiang J. Wang. Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. , 2011, Quantitative imaging in medicine and surgery.
[39] Q. Pankhurst,et al. Nanoparticles functionalized with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells. , 2010, Biomaterials.
[40] M. Westphal,et al. Treatment of malignant glioma: a problem beyond the margins of resection , 2001, Journal of Cancer Research and Clinical Oncology.
[41] Xin Gao,et al. Prostate stem cell antigen-targeted nanoparticles with dual functional properties: in vivo imaging and cancer chemotherapy , 2012, International journal of nanomedicine.
[42] S. Vallabhajosula,et al. Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen. , 2003, The Journal of urology.
[43] R Weissleder,et al. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. , 2000, Radiology.
[44] L. Yakovleva,et al. Brain tumor magnetic targeting and biodistribution of superparamagnetic iron oxide nanoparticles linked with 70-kDa heat shock protein study by nonlinear longitudinal response , 2015 .
[45] M. Krieger,et al. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL , 2006, Journal of Molecular Medicine.
[46] C. Fan,et al. Protein corona-mediated mitigation of cytotoxicity of graphene oxide. , 2011, ACS nano.
[47] S. Krol,et al. Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier. , 2013, Chemical reviews.
[48] S Moein Moghimi,et al. Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering. , 2010, ACS nano.
[49] D. Lockhart,et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[50] Stefan Tenzer,et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.
[51] Kai Chen,et al. PET/NIRF/MRI triple functional iron oxide nanoparticles. , 2010, Biomaterials.
[52] Morteza Mahmoudi,et al. Variation of protein corona composition of gold nanoparticles following plasmonic heating. , 2014, Nano letters.
[53] T. Thongtem,et al. Magnetic-EpCAM nanoprobe as a new platform for efficient targeting, isolating and imaging hepatocellular carcinoma , 2015 .
[54] E. Neuwelt,et al. An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions. , 2005, AJNR. American journal of neuroradiology.
[55] D. Shahbazi-Gahrouei,et al. Superparamagnetic iron oxide-C595: Potential MR imaging contrast agents for ovarian cancer detection , 2013, Journal of medical physics.
[56] V. Rotello,et al. Engineering the nanoparticle-protein interface for cancer therapeutics. , 2015, Cancer treatment and research.
[57] Miqin Zhang,et al. Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. , 2006, Journal of biomedical materials research. Part A.
[58] R. Niu,et al. Polymeric liposomes-coated superparamagnetic iron oxide nanoparticles as contrast agent for targeted magnetic resonance imaging of cancer cells. , 2011, Langmuir : the ACS journal of surfaces and colloids.
[59] Bo Yan,et al. Fabrication of Corona-Free Nanoparticles with Tunable Hydrophobicity , 2014, ACS nano.
[60] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[61] Karthikeyan Subramani,et al. Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. , 2011, Chemical reviews.
[62] Eiichi Fukushima,et al. Short data‐acquisition times improve projection images of lung tissue , 2007, Magnetic resonance in medicine.
[63] Eric C. Holland,et al. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma , 2010, Nature Reviews Cancer.
[64] Jie Li,et al. Identification of an aptamer targeting hnRNP A1 by tissue slide‐based SELEX , 2009, The Journal of pathology.
[65] J Listerud,et al. T2* and proton density measurement of normal human lung parenchyma using submillisecond echo time gradient echo magnetic resonance imaging. , 1999, European journal of radiology.
[66] Hye Won Kim,et al. TCL-SPION-enhanced MRI for the detection of lymph node metastasis in murine experimental model. , 2011, Academic radiology.
[67] W Semmler,et al. Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in Vivo by using transferrin receptor pathways , 1998, Magnetic resonance in medicine.
[68] T. Allen. Ligand-targeted therapeutics in anticancer therapy , 2002, Nature Reviews Cancer.
[69] A Ciechanover,et al. Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. Effect of lysosomotropic agents. , 1983, The Journal of biological chemistry.
[70] G. Caracciolo,et al. Lipid composition: a “key factor” for the rational manipulation of the liposome–protein corona by liposome design , 2015 .
[71] Hong Xu,et al. Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment. , 2010, ACS nano.
[72] Xiaohua Huang,et al. Nanotechnology for enrichment and detection of circulating tumor cells. , 2015, Nanomedicine.
[73] Ralph Weissleder,et al. Nanoparticle imaging of integrins on tumor cells. , 2006, Neoplasia.
[74] C. Casals,et al. Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A. , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[75] T. Nishimura,et al. Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma , 2005, British Journal of Cancer.
[76] Hui Mao,et al. Casein-coated iron oxide nanoparticles for high MRI contrast enhancement and efficient cell targeting. , 2013, ACS applied materials & interfaces.
[77] B. Levin,et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.
[78] S. Gambhir,et al. Affibody-based nanoprobes for HER2-expressing cell and tumor imaging. , 2011, Biomaterials.
[79] M. Mahmoudi,et al. Slight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles. , 2013, Nanoscale.
[80] P Stroeve,et al. Cell toxicity of superparamagnetic iron oxide nanoparticles. , 2009, Journal of colloid and interface science.
[81] A. Barzegari,et al. Fe3O4 nanoparticles engineered for plasmid DNA delivery to Escherichia coli , 2014, Journal of Nanoparticle Research.
[82] Matthew Cotten,et al. Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis , 1994 .
[83] Dmitri Artemov,et al. MR molecular imaging of the Her‐2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles , 2003, Magnetic resonance in medicine.
[84] V. Reuter,et al. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. , 1999, Cancer research.
[85] Huimao Zhang,et al. Lectin-conjugated Fe2O3@Au core@Shell nanoparticles as dual mode contrast agents for in vivo detection of tumor. , 2014, Molecular pharmaceutics.
[86] A. Jemal,et al. Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.
[87] Sarit S. Agasti,et al. Modulation of the catalytic behavior of alpha-chymotrypsin at monolayer-protected nanoparticle surfaces. , 2006, Journal of the American Chemical Society.
[88] M. Mahmoudi,et al. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. , 2011, Advanced drug delivery reviews.
[89] E. Giralt,et al. Cell-Penetrating cis-γ-Amino-l-Proline-Derived Peptides , 2005 .
[90] Efstathios Karathanasis,et al. Imaging metastasis using an integrin-targeting chain-shaped nanoparticle. , 2012, ACS nano.
[91] Carolyn J. Anderson,et al. Folate Receptor-Targeted Multimodality Imaging of Ovarian Cancer in a Novel Syngeneic Mouse Model , 2014, Molecular pharmaceutics.
[92] C. Alexiou,et al. Locoregional cancer treatment with magnetic drug targeting. , 2000, Cancer research.
[93] Chengzhong Yu,et al. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells. , 2013, Nanoscale.
[94] B. Nikolaev,et al. Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION–EGF) for targeting brain tumors , 2014, International journal of nanomedicine.
[95] Lei Zhao,et al. TiO2 nanoparticles promote beta-amyloid fibrillation in vitro. , 2008, Biochemical and biophysical research communications.
[96] Philip M. Kelly,et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.
[97] S. Larson,et al. 89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo , 2010, The Journal of Nuclear Medicine.
[98] L R Coney,et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. , 1992, Cancer research.
[99] S. Berensmeier. Magnetic particles for the separation and purification of nucleic acids , 2006, Applied Microbiology and Biotechnology.
[100] J. Helliwell,et al. The determination of protonation states in proteins. , 2007, Acta crystallographica. Section D, Biological crystallography.
[101] W. Cai,et al. Specific targeting of gliomas with multifunctional superparamagnetic iron oxide nanoparticle optical and magnetic resonance imaging contrast agents , 2007, Acta Pharmacologica Sinica.
[102] D. Cheresh,et al. Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.
[103] M. D. Blanco,et al. Targeted Nanoparticles for Cancer Therapy , 2012 .
[104] Miqin Zhang,et al. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. , 2005, Langmuir : the ACS journal of surfaces and colloids.
[105] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.
[106] J. Rhee,et al. Immune cell-specific delivery of beta-glucan-coated iron oxide nanoparticles for diagnosing liver metastasis by MR imaging , 2012 .
[107] Joseph M. DeSimone,et al. Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.
[108] M. Mahmoudi,et al. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges , 2014, Expert opinion on drug delivery.
[109] J. Witjes,et al. Ferumoxtran-10 ultrasmall superparamagnetic iron oxide-enhanced diffusion-weighted imaging magnetic resonance imaging for detection of metastases in normal-sized lymph nodes in patients with bladder and prostate cancer: do we enter the era after extended pelvic lymph node dissection? , 2013, European urology.
[110] Duxin Sun,et al. Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release. , 2010, Molecular pharmaceutics.
[111] R. Todd,et al. Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes. , 1998, Journal of immunology.
[112] P. Maisonneuve,et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. , 2008, Gastroenterology.
[113] M. Mahmoudi,et al. Toxicity of nanoparticles , 2015 .
[114] Lara K Mahal,et al. Deciphering the glycocode: the complexity and analytical challenge of glycomics. , 2007, Current opinion in chemical biology.
[115] M. Khazaeli,et al. Use of chlorotoxin for targeting of primary brain tumors. , 1998, Cancer research.
[116] Donald P Frush,et al. Computed tomography and radiation: understanding the issues. , 2004, Journal of the American College of Radiology : JACR.
[117] M. Mahmoudi,et al. Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles. , 2013, Nanoscale.
[118] G. Fernández,et al. Fibrinogen Promotes Neutrophil Activation and Delays Apoptosis1 , 2001, The Journal of Immunology.
[119] Ji-chen Wang,et al. Preparation of magnetic resonance probes using one-pot method for detection of hepatocellular carcinoma. , 2015, World journal of gastroenterology.
[120] S. Vallabhajosula,et al. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[121] G. Liu,et al. Targeted Herceptin–dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI , 2009, JBIC Journal of Biological Inorganic Chemistry.
[122] Wole Soboyejo,et al. LHRH-conjugated Magnetic Iron Oxide Nanoparticles for Detection of Breast Cancer Metastases , 2006, Breast Cancer Research and Treatment.
[123] Erkki Ruoslahti,et al. αv Integrins as receptors for tumor targeting by circulating ligands , 1997, Nature Biotechnology.
[124] L. Brannon-Peppas,et al. Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.
[125] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[126] V. Rotello,et al. Synthetic "chaperones": nanoparticle-mediated refolding of thermally denatured proteins. , 2008, Chemical communications.
[127] Hao Zeng,et al. Size-controlled synthesis of magnetite nanoparticles. , 2002, Journal of the American Chemical Society.
[128] D. Shahbazi-Gahrouei,et al. Detection of MUC1-Expressing Ovarian Cancer by C595 Monoclonal Antibody-Conjugated SPIONs Using MR Imaging , 2013, TheScientificWorldJournal.
[129] B. Tombach,et al. Hepatic MRI with SPIO: detection and characterization of focal liver lesions , 1998, European Radiology.
[130] Forrest M Kievit,et al. Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONs. , 2012, ACS nano.
[131] Jianjun Cheng,et al. Protein corona significantly reduces active targeting yield. , 2013, Chemical communications.
[132] J. Willmann,et al. Ultrasound Molecular Imaging in a Human CD276 Expression–Modulated Murine Ovarian Cancer Model , 2014, Clinical Cancer Research.
[133] Yongmin Chang,et al. Particle size dependence of relaxivity for silica-coated iron oxide nanoparticles , 2012 .
[134] M. Mahmoudi,et al. Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake. , 2016, Biomaterials.
[135] Chaoyong James Yang,et al. In vitro selection of DNA aptamers for metastatic breast cancer cell recognition and tissue imaging. , 2014, Analytical chemistry.
[136] James I. Cohen,et al. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. , 2002, AJNR. American journal of neuroradiology.
[137] Xiaohong Fang,et al. Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells. , 2009, The Analyst.
[138] Lisa Brannon-Peppas,et al. Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.
[139] Mingwu Shen,et al. Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging. , 2014, Biomaterials.
[140] Warren S Warren,et al. Molecular MRI for sensitive and specific detection of lung metastases , 2010, Proceedings of the National Academy of Sciences.
[141] R. Srivastava. Scavenger receptor class B type I expression in murine brain and regulation by estrogen and dietary cholesterol , 2003, Journal of the Neurological Sciences.
[142] X. Shuai,et al. A dual ligand targeted nanoprobe with high MRI sensitivity for diagnosis of breast cancer , 2014, Chinese Journal of Polymer Science.
[143] Nishanth Krishnamurthy,et al. Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors. , 2010, ACS nano.
[144] Morteza Mahmoudi,et al. Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. , 2011, Advances in colloid and interface science.
[145] Wufan Chen,et al. Anti-αvβ3 antibody guided three-step pretargeting approach using magnetoliposomes for molecular magnetic resonance imaging of breast cancer angiogenesis , 2013, International journal of nanomedicine.
[146] H. Gu,et al. Mono-dispersed high magnetic resonance sensitive magnetite nanocluster probe for detection of nascent tumors by magnetic resonance molecular imaging. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[147] S. Jayasena. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. , 1999, Clinical chemistry.
[148] Andrei Iagaru,et al. Molecular imaging can accelerate anti-angiogenic drug development and testing , 2007, Nature Clinical Practice Oncology.
[149] K. Higaki,et al. Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. , 2007, International journal of pharmaceutics.
[150] James Chen Yong Kah,et al. Exploiting the protein corona around gold nanorods for loading and triggered release. , 2012, ACS nano.
[151] D. Jans,et al. Protein transduction: cell penetrating peptides and their therapeutic applications. , 2006, Current medicinal chemistry.
[152] Stephen Yip,et al. Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers , 2010, The Lancet Neurology.
[153] Iseult Lynch,et al. What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.
[154] Andrew Emili,et al. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. , 2012, Journal of the American Chemical Society.
[155] Yanbing Zhao,et al. pH/temperature sensitive magnetic nanogels conjugated with Cy5.5-labled lactoferrin for MR and fluorescence imaging of glioma in rats. , 2013, Biomaterials.
[156] X. Qin,et al. Glycan changes: cancer metastasis and anti-cancer vaccines , 2010, Journal of Biosciences.
[157] R. Weissleder,et al. The transferrin receptor: a potential molecular imaging marker for human cancer. , 2003, Neoplasia.
[158] S. Gambhir,et al. Multimodality imaging of tumor xenografts and metastases in mice with combined small-animal PET, small-animal CT, and bioluminescence imaging. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[159] Abhalaxmi Singh,et al. Long Circulating Lectin Conjugated Paclitaxel Loaded Magnetic Nanoparticles: A New Theranostic Avenue for Leukemia Therapy , 2011, PloS one.
[160] Morteza Mahmoudi,et al. Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles. , 2011, Nanoscale.
[161] Sunjoo Jeong,et al. In vitro selection of RNA aptamer and specific targeting of ErbB2 in breast cancer cells. , 2011, Nucleic acid therapeutics.
[162] Ji-Hee Kim,et al. Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer. , 2010, Biomaterials.
[163] Shaojun Dong,et al. pH-dependent protein conformational changes in albumin:gold nanoparticle bioconjugates: a spectroscopic study. , 2007, Langmuir : the ACS journal of surfaces and colloids.
[164] Jun Fang,et al. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.
[165] Jinwoo Cheon,et al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. , 2005, Journal of the American Chemical Society.
[166] W. Fair,et al. Expression of the prostate-specific membrane antigen. , 1994, Cancer research.
[167] Weihong Tan,et al. Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells. , 2006, Analytical chemistry.
[168] N. Kay,et al. Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies? , 1994, Clinical and diagnostic laboratory immunology.
[169] Robert Langer,et al. Superparamagnetic Iron Oxide Nanoparticle-Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy , 2011 .
[170] Hwa-Jeong Lee,et al. Targeted delivery of mannan-coated superparamagnetic iron oxide nanoparticles to antigen-presenting cells for magnetic resonance-based diagnosis of metastatic lymph nodes in vivo. , 2011, Acta biomaterialia.
[171] Donghoon Lee,et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. , 2008, Small.
[172] S. Gambhir,et al. Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects. , 2009, Cancer research.
[173] E. Neuwelt,et al. Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours , 2004, Neuropathology and applied neurobiology.
[174] H. Sontheimer,et al. Chlorotoxin, a scorpion‐derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin , 2002, Glia.